Another existing drug shows promise against COVID-19

ISLAMABAD, August 20 (online): New research demonstrates that an existing drug, called Ebselen, has the potential to disrupt SARS-CoV-2. This is the virus responsible for COVID-19.

The recent study could help develop Ebselen as a new treatment for COVID-19. The study also provides clues as to which other existing drugs scientists should prioritize in the hunt for effective therapies.

The sudden emergence and rapid spread of COVID-19 has catalyzed a significant amount of research into possible treatments and therapies.

SARS-CoV-2 bears many similarities to other corona viruses, such as SARS-CoV, which is responsible for severe acute respiratory syndrome (SARS). However, “re-purposing SARS drugs for COVID-19 may not be effective,” according to the authors of the new study.

Upon confiscation of the Palestinian ambassador’s car, a major court order to the FBR

Stay tuned to Baaghi TV for latest news and updates!